A novel study indicated that women over forty years of age are not likely to garner benefits to a large extent from inoculation for the virus causing cervical cancer. Immunization for HPV (human papillomavirus), is advised for all women up to twenty-six years of age and even for girls of nine years of age. The latest study headed by author Dr. Ana Cecilia Rodriguez stated that the study was conducted for ascertaining if women in the older age band could be shielded alongside observing outline of HPV infection as women grew older. The study did a follow-up of over nine thousand women from Costa Rica in the age group of nineteen to 97 years and screened them for cancer-causing HPV infections and originators to cervical cancer. The study that was lately released online in The Journal of the National  [...]

Cervical Cancer is a serious health problem affecting women globally. It is the third prevalent kind of cancer in women. Nearly 80% of cervical cancer cases are from developing countries where cervical cancer is the second most prevalent reason behind cancer fatalities among women. The Human Papilloma Virus The finding that the HPV or Human Papillomavirus virus causes cervical cancer has opened novel avenues in its prevention and treatment. There seems to be a strong association between the occurrence of cervical cancer and the commonness of HPV infection in the populace. Above hundred HPV types has been detected, nearly forty are found to affect the genital region and at least fifteen are deemed oncogenic; 2 other types cause majority of the cases of genital warts. HPV linked Diseases Globally,  [...]

Patients having particular alterations in the cancer genome are at 3-4 times higher risk of recurrence subsequent to the standard cervical cancer treatment when evaluated against those patients that did not have such alterations. This was part of the study conducted by Norwegian researchers and has been printed in the 13th November edition in the open-access academic journal ‘PLoS Genetics’. The research indicates that particular genetic variations are decisive stages revealing that the disease is progressing to a more belligerent and treatment-immune phase. Cervical cancer is one of the most prevalent forms of cancer that affects women globally and a key reason behind cancer-linked fatalities. Hence, the researchers have endeavoured to investigate if these genetic alterations could provide  [...]

The FDA (Food and Drug Administration) lately approved the use of Cervarix, the second vaccine intended for averting infections occurring due to HPV or human papilloma virus, a grave risk factor that could lead to cervical cancer. The Cervarix vaccine (Manufacturer – GlaxoSmithKline) is aimed at combating high risk HPV strains 16 and 18 that are the offenders for nearly seventy percent of all occurring cervical cancers, and has got the green-light from the FDA to be used in girls and women in the age group of 10-25 years. HPV is a set of more than hundred related virus forms that could be transmitted via skin contact – inclusive of intercourse –vaginal or anal and could even be transmitted at the time of oral sexual contact. HPV leads to the appearance of genital warts, although several  [...]

Cervical cancers originate as a non-malignant irregularity of cells on the surface of the cervix. These abnormal cells comprise of dysplasia, squamous intraepithelial lesions (SIL) and carcinoma in situ. When unnoticed or untreated, these pre-invasive anomalies ultimately could attack the normal cervical cells. Due to this cancer could consequently develop that would invade adjacent tissues or lymph nodes and probably metastasize to other areas in the body. Cervical Cancer Symptoms: In case the normal cervical cells have not been attacked by these lesions, the treatments involved would be comparatively simple and uncomplicated. Pre-cancerous variations in the cervix generally are not painful and are usually asymptomatic and are spotted only following a pelvic examination and a Pap smear test.  [...]

The initial changes occurring in the cells lining the cervix is known as dysplasia. Treating these early changes could lower the risk of developing cervical cancer. Additionally, the risk factors associated with anomalous cell changes could also be reduced. Pap test Screening Cervical cancer could be most effectually screened via the Pap test. Getting Pap tests done at regular time intervals mostly aids in detection of changes in the cervical cells prior to them taking a malignant form. The irregular cell changes could be prevented from turning cancerous by undergoing screening at regular intervals and treating cervical cells anomalies could avert the anomalous cell variations from developing into cancer. It is crucial to re-visit the doctor in case of any abnormal outcome of the Pap Test. Smoking  [...]

Precancerous alterations in the cervical cells and cervical cancer are undecipherable to the naked vision. Specialised testing and devices are required for diagnosing such conditions. Pap smear screenings are carried out for detecting pre-cancerous and cancerous conditions, though it doesn’t provide the absolute analysis. In case of any anomalous changes being spotted, the cervix is generally inspected microscopically. This is known as colposcopy. During biopsy, the surgical removal of a small section of the tissue is done that is forwarded for further laboratory investigation. Other testing methods might comprise of: Endocervical curettage or ECC: is employed for examination of the cervical region. Cold Knife Cone biopsy: This surgical procedure is conducted for getting anomalous  [...]